Related Experiment Video
Updated: Mar 24, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
19.4K
[New medicines at an acceptable cost?]
1Geneesmiddelenbulletin, Utrecht.
Nederlands Tijdschrift Voor Geneeskunde
|March 17, 2016
Summary
The Dutch medicine access system is failing due to high costs. Reforms are proposed, including restrictions on patents and market protection, to ensure rational pharmacotherapy and patient access to thoroughly evaluated medicines.
Area of Science:
- Health Policy
- Pharmacoeconomics
- Pharmaceutical Regulation
Background:
- The current Dutch system for accessing new medicines is unsustainable due to escalating costs.
- Concerns exist regarding the pricing and market access of pharmaceuticals.
- The need for rational pharmacotherapy is paramount for patient well-being.
Purpose of the Study:
- To analyze the failures of the current medicine access system in the Netherlands.
- To propose government-led reforms to address medicine pricing and market access.
- To advocate for enhanced patient protection through rigorous evaluation of new medicines.
Main Methods:
- Policy analysis of the existing medicine access framework.
- Review of current pharmaceutical pricing and patent regulations.
- Examination of clinical evidence requirements for market authorization.
Main Results:
- The current system's cost trajectory is deemed unsustainable.
- Restrictions on patenting and market protection are suggested as cost-containment measures.
- The study highlights the inadequacy of rapid market access without robust clinical evidence.
Conclusions:
- Government intervention is necessary to reform the medicine access system.
- Proposals include establishing state-owned biotechnology firms and rejecting non-inferiority studies.
- Ensuring thorough evaluation of medicines, even in end-of-life care, is crucial for patient rights.
Related Concept Videos
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
238
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
238
01:28Drug Products: Biologics, Biosimilars and Interchangeables
348
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
348
01:26FDA Approved Drugs: Changes to Approved Drugs
320
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
320
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:26Pharmaceutical Equivalents
254
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
254
01:17Drug Nomenclature
3.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.6K